Irish board wants to keep 2013 drug fees at around current level
This article was originally published in Scrip
Executive Summary
The Irish Medicines Board is inviting feedback on its plans to ensure that its fees for various drug and device-related activities in 2013 are kept at more or less the current level. Though the IMB plans to introduce some new fee types, it has proposed some "adjustments" to the fee structure so that there is no overall increase.